FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Dettling

Research Profile

Disorders

Chemicals & Drugs

Physiology

Concepts & Ideas

Activities & Behaviors

Schizophrenic Psychology

Procedures

Genes & Molecular Sequences

Alleles

Co-author Network

Publications

TOP 3
Linn K Kuehl; Emily S L Brandt; Michael Dettling; Eric Hahn; Andres H Neuhaus
Exploring the time course of N170 repetition suppression: a preliminary study.
Constanze Hahn; Eric Hahn; Michael Dettling; Onur Güntürkün; Thi Minh Tam Ta; Andres H Neuhaus
Effects of smoking history on selective attention in schizophrenia.
Eric Hahn; Linn K Kuehl; Andres H Neuhaus; Claudia Ruehl; Thi Minh Tam Ta; Constanze Hahn; Michael Dettling
Test-retest reliability of Attention Network Test measures in schizophrenia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Dettling (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Linn K Kuehl; Emily S L Brandt; Michael Dettling; Eric Hahn; Andres H Neuhaus
Exploring the time course of N170 repetition suppression: a preliminary study.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2013;87(2):183-8.
2012: Constanze Hahn; Eric Hahn; Michael Dettling; Onur Güntürkün; Thi Minh Tam Ta; Andres H Neuhaus
Effects of smoking history on selective attention in schizophrenia.
Neuropharmacology 2012;62(4):1897-902.
2011: Eric Hahn; Linn K Kuehl; Andres H Neuhaus; Claudia Ruehl; Thi Minh Tam Ta; Constanze Hahn; Michael Dettling
Test-retest reliability of Attention Network Test measures in schizophrenia.
Schizophrenia research 2011;133(1-3):218-22.
2011: Andres H Neuhaus; Carolin Opgen-Rhein; Thi Minh Tam Ta; Carsten Urbanek; Constanze Hahn; Eric Hahn; Michael Dettling
Visual P3 amplitude modulation deficit in schizophrenia is independent of duration of illness.
Schizophrenia research 2011;130(1-3):210-5.
2011: Andres H Neuhaus; Florin C Popescu; Cristian Grozea; Eric Hahn; Constanze Hahn; Carolin Opgen-Rhein; Carsten Urbanek; Michael Dettling
Single-subject classification of schizophrenia by event-related potentials during selective attention.
NeuroImage 2011;55(2):514-21.
2011: Andres H Neuhaus; Christine Karl; Eric Hahn; Niklas R Trempler; Carolin Opgen-Rhein; Carsten Urbanek; Constanze Hahn; Thi Minh Tam Ta; Michael Dettling
Dissection of early bottom-up and top-down deficits during visual attention in schizophrenia.
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology 2011;122(1):90-8.
2010: Andres H Neuhaus; Niklas R Trempler; Eric Hahn; Alexander Luborzewski; Christine Karl; Constanze Hahn; Carolin Opgen-Rhein; Carsten Urbanek; Rainer Schaub; Michael Dettling
Evidence of specificity of a visual P3 amplitude modulation deficit in schizophrenia.
Schizophrenia research 2010;124(1-3):119-26.
2010: Carolin Opgen-Rhein; Eva Janina Brandl; Daniel J Müller; Andres H Neuhaus; Arun K Tiwari; Thomas Sander; Michael Dettling
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
Pharmacogenomics 2010;11(6):773-80.
2010: Andres H Neuhaus; Carsten Urbanek; Carolin Opgen-Rhein; Eric Hahn; Thi Minh Tam Ta; Simone Koehler; Melanie Gross; Michael Dettling
Event-related potentials associated with Attention Network Test.
International journal of psychophysiology : official journal of the International Organization of Psychophysiology 2010;76(2):72-9.
2010: Carsten Urbanek; Nicholetta Weinges-Evers; Judith Bellmann-Strobl; Markus Bock; Jan Dörr; Eric Hahn; Andres H Neuhaus; Carolin Opgen-Rhein; Thi Minh Tam Ta; Katja Herges; Caspar F Pfueller; Helena Radbruch; Klaus-Dieter Wernecke; Stephanie Ohlraun; Frauke Zipp; Michael Dettling; Friedemann Paul
Attention Network Test reveals alerting network dysfunction in multiple sclerosis.
Multiple sclerosis (Houndmills, Basingstoke, England) 2010;16(1):93-9.
2009: Andres H Neuhaus; Carolin Opgen-Rhein; Carsten Urbanek; Melanie Gross; Eric Hahn; Thi Minh Tam Ta; Simone Koehler; Michael Dettling
Spatiotemporal mapping of sex differences during attentional processing.
Human brain mapping 2009;30(9):2997-3008.
2009: Carsten Urbanek; Andres H Neuhaus; Carolin Opgen-Rhein; Silke Strathmann; Nicol Wieseke; Rainer Schaub; Eric Hahn; Michael Dettling
Attention network test (ANT) reveals gender-specific alterations of executive function in schizophrenia.
Psychiatry research 2009;168(2):102-9.
2009: Andres H Neuhaus; Carolin Opgen-Rhein; C Urbanek; Eckhart Hahn; T M T Ta; M Seidelsohn; S Strathmann; F Kley; N Wieseke; Thomas Sander; Michael Dettling
COMT Val 158 Met polymorphism is associated with cognitive flexibility in a signal discrimination task in schizophrenia.
Pharmacopsychiatry 2009;42(4):141-4.
2008: Carolin Opgen-Rhein; Andres H Neuhaus; Carsten Urbanek; Eric Hahn; Thomas Sander; Michael Dettling
Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test.
Schizophrenia bulletin 2008;34(6):1231-9.
2008: Michael Dettling; Carolin Opgen-Rhein; Ion Anghelescu
Escitalopram, problem-solving therapy, and poststroke depression.
JAMA : the journal of the American Medical Association 2008;300(15):1757; author reply 1758-9.
2008: Carolin Opgen-Rhein; Michael Dettling
Clozapine-induced agranulocytosis and its genetic determinants.
Pharmacogenomics 2008;9(8):1101-11.
2008: Michael Dettling; Ion Anghelescu; Malek Bajbouj
Electroconvulsive therapy for depression.
The New England journal of medicine 2008;358(6):645; author reply 646.
2007: Michael Dettling; Ingolf Cascorbi; Carolin Opgen-Rhein; R Schaub
Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens.
The pharmacogenomics journal 2007;7(5):325-32.
2007: Andres H Neuhaus; Simone Koehler; Carolin Opgen-Rhein; Carsten Urbanek; Eric Hahn; Michael Dettling
Selective anterior cingulate cortex deficit during conflict solution in schizophrenia: an event-related potential study.
Journal of psychiatric research 2007;41(8):635-44.
2007: Katrin Körtner; Andres H Neuhaus; Falk Schürer; Michael Dettling
Eosinophilia indicating subclinical clozapine-induced pericarditis.
The Journal of clinical psychiatry 2007;68(7):1147-8.
2007: Carolin Opgen-Rhein; Andres H Neuhaus; Michael Dettling
Transient hyperglycemia and decreased glucose tolerance during antipsychotic monotherapy with amisulpride.
Journal of clinical psychopharmacology 2007;27(1):92-3.
2006: Michael Dettling; Carolin Opgen-Rhein; Arnim Quante; Ion Anghelescu
Fluoxetine for treatment of anorexia nervosa.
JAMA : the journal of the American Medical Association 2006;296(20):2439-40; author reply 2440.
2006: Michael Dettling; Carolin Opgen-Rhein; Ion Anghelescu
Homocysteine lowering and cognitive performance.
The New England journal of medicine 2006;355(13):1390; author reply 1391.
2006: Michael Dettling; Ion Anghelescu
Antipsychotic drugs and schizophrenia.
The New England journal of medicine 2006;354(3):298-300; author reply 298-300.
2005: Igor Mosyagin; Ingolf Cascorbi; Rainer Schaub; Timo Krüger; Michael Dettling
Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?
Journal of clinical psychopharmacology 2005;25(5):435-40.
2005: Francesca Regen; A Merkl; Isabella Heuser; Michael Dettling; Ion Anghelescu
[Diabetes and depression].
Deutsche medizinische Wochenschrift (1946) 2005;130(17):1097-102.
2005: Michael Dettling; Edward Gabrielson; Giovanni Parmigiani
Searching for differentially expressed gene combinations.
Genome biology 2005;6(10):R88.
2004: Michael Dettling
BagBoosting for tumor classification with gene expression data.
Bioinformatics (Oxford, England) 2004;20(18):3583-93.
2004: Igor Mosyagin; Michael Dettling; Ivar Roots; Bruno Mueller-Oerlinghausen; Ingolf Cascorbi
Impact of myeloperoxidase and NADPH-oxidase polymorphisms in drug-induced agranulocytosis.
Journal of clinical psychopharmacology 2004;24(6):613-7.
2004: Timo Krüger; Manfred Schönhoff; Michael Dettling
[Neurocognition, psychosocial outcome and vocational integration].
Psychiatrische Praxis 2004;31 Suppl 2():S224-9.
2004: Carolin Opgen-Rhein; Andres H Neuhaus; Carsten Urbanek; Michael Dettling
[New strategies in schizophrenia: impact of endophentotypes].
Psychiatrische Praxis 2004;31 Suppl 2():S194-9.
2004: Michael Dettling; Manfred Schönhoff
[Social psychiatry and schizophrenia--changes and perspectives].
Psychiatrische Praxis 2004;31 Suppl 2():S185-8.
2004: Tim Neumann; Bruno Neuner; Larry M Gentilello; Edith Weiss-Gerlach; Henriette Mentz; Jordan Rettig; Torsten Schröder; Helmar Wauer; Christian Müller; Michael Schütz; Karl Mann; Gerda Siebert; Michael Dettling; Joachim M Müller; Wolfgang J Kox; Claudia D Spies
Gender differences in the performance of a computerized version of the alcohol use disorders identification test in subcritically injured patients who are admitted to the emergency department.
Alcoholism, clinical and experimental research 2004;28(11):1693-701.
2004: Oliver Teuffel; David R Betts; Michael Dettling; R Schaub; Beat W Schäfer; Felix K Niggli
Prenatal origin of separate evolution of leukemia in identical twins.
Leukemia 2004;18(10):1624-9.
2004: Marco Wachtel; Michael Dettling; Ewa Koscielniak; Sabine Stegmaier; Jörn Treuner; Katja Simon-Klingenstein; Peter Bühlmann; Felix K Niggli; Beat W Schäfer
Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.
Cancer research 2004;64(16):5539-45.
2004: I Heuser; Michael Dettling
[Health economic aspects of medical care and therapeutic options for schizophrenic and depressive patients in Germany].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2004;47(8):745-50.
2004: Michael Dettling; Thomas Sander; Markus Weber; Ortrud K Steinlein
Mutation analysis of the ryanodine receptor gene isoform 3 (RYR3) in recurrent neuroleptic malignant syndrome.
Journal of clinical psychopharmacology 2004;24(4):471-3.
2004: Oliver Teuffel; Michael Dettling; Gunnar Cario; Martin Stanulla; Martin Schrappe; Peter Bühlmann; Felix K Niggli; Beat W Schäfer
Gene expression profiles and risk stratification in childhood acute lymphoblastic leukemia.
Haematologica 2004;89(7):801-8.
2004: Robert Gentleman; Vincent J Carey; Douglas M Bates; Ben Bolstad; Michael Dettling; Sandrine Dudoit; Byron Ellis; Laurent Gautier; Yongchao Ge; Jeff Gentry; Kurt Hornik; Torsten Hothorn; Wolfgang Huber; Stefano Iacus; Rafael A Irizarry; Franz Leisch; Cheng Li; Martin Maechler; Anthony J Rossini; Gunther Sawitzki; Colin Smith; Gordon Smyth; Luke Tierney; Jean Y H Yang; Jianhua Zhang
Bioconductor: open software development for computational biology and bioinformatics.
Genome biology 2004;5(10):R80.
2003: Michael Dettling; Peter Bühlmann
Boosting for tumor classification with gene expression data.
Bioinformatics (Oxford, England) 2003;19(9):1061-9.
2002: Michael Dettling; Peter Bühlmann
Supervised clustering of genes.
Genome biology 2002;3(12):RESEARCH0069.
2002: Peter Neu; Sepp Seyfert; Jürgen Brockmöller; Michael Dettling; Peter Marx
Neuroleptic malignant syndrome in a patient with succinic semialdehyde dehydrogenase deficiency.
Pharmacopsychiatry 2002;35(1):26-8.
2001: Rolf Kaiser; Pierre-Benoit Tremblay; Jürgen Schmider; M Henneken; Michael Dettling; Bruno Müller-Oerlinghausen; Ralf Uebelhack; Ivar Roots; Jürgen Brockmöller
Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia.
Molecular psychiatry 2001;6(2):179-85.
2001: Michael Dettling; R T Schaub; Bruno Mueller-Oerlinghausen; Ivar Roots; Ingolf Cascorbi
Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.
Pharmacogenetics 2001;11(2):135-41.
2001: Michael Dettling; Ingolf Cascorbi; Ivar Roots; Bruno Mueller-Oerlinghausen
Genetic determinants of clozapine-induced agranulocytosis: recent results of HLA subtyping in a non-jewish caucasian sample.
Archives of general psychiatry 2001;58(1):93-4.
2000: Michael Dettling; Christoph Sachse; Bruno Müller-Oerlinghausen; Ivar Roots; Jürgen Brockmöller; A Rolfs; Ingolf Cascorbi
Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.
Pharmacopsychiatry 2000;33(6):218-20.
2000: Michael Dettling; Christoph Sachse; Jürgen Brockmöller; Jürgen Schley; Bruno Müller-Oerlinghausen; I Pickersgill; A Rolfs; R T Schaub; Jürgen Schmider
Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
Psychopharmacology 2000;152(1):80-6.
2000: R Kaiser; M Könneker; M Henneken; Michael Dettling; B Müller-Oerlinghausen; Ivar Roots; Jürgen Brockmöller
Dopamine D4 receptor 48-bp repeat polymorphism: no association with response to antipsychotic treatment, but association with catatonic schizophrenia.
Molecular psychiatry 2000;5(4):418-24.
1999: Christoph Sachse; S Ruschen; Michael Dettling; Jürgen Schley; Steffen Bauer; Bruno Müller-Oerlinghausen; Ivar Roots; Jürgen Brockmöller
Flavin monooxygenase 3 (FMO3) polymorphism in a white population: allele frequencies, mutation linkage, and functional effects on clozapine and caffeine metabolism.
Clinical pharmacology and therapeutics 1999;66(4):431-8.
1999: Michael Dettling; Ingolf Cascorbi; R Hellweg; U Deicke; L Weise; Bruno Müller-Oerlinghausen
Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?
Pharmacopsychiatry 1999;32(3):110-2.
1998: Michael Dettling; Bruno Müller-Oerlinghausen; P Britsch
Clozapine treatment of HIV-associated psychosis--too much bone marrow toxicity?
Pharmacopsychiatry 1998;31(4):156-7.
1998: Isabella Heuser; Garth Bissette; Michael Dettling; U Schweiger; U Gotthardt; Jürgen Schmider; Claas-Hinrich Lammers; Charles Nemeroff; Florian Holsboer
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment.
Depression and anxiety 1998;8(2):71-9.
1997: Ulrich Finckh; Hans Rommelspacher; S Kuhn; P Dufeu; G Otto; A Heinz; Michael Dettling; M Giraldo-Velasquez; J Pelz; KJ Gräf; H Harms; Thomas Sander; Lutz G Schmidt; A Rolfs
Influence of the dopamine D2 receptor (DRD2) genotype on neuroadaptive effects of alcohol and the clinical outcome of alcoholism.
Pharmacogenetics 1997;7(4):271-81.
1996: A Heinz; P Dufeu; S Kuhn; Michael Dettling; KJ Gräf; I Kürten; Hans Rommelspacher; Lutz G Schmidt
Psychopathological and behavioral correlates of dopaminergic sensitivity in alcohol-dependent patients.
Archives of general psychiatry 1996;53(12):1123-8.
1996: A Heinz; Thomas Sander; H Harms; Ulrich Finckh; S Kuhn; P Dufeu; Michael Dettling; KJ Gräf; A Rolfs; Hans Rommelspacher; Lutz G Schmidt
Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism.
Alcoholism, clinical and experimental research 1996;20(6):1109-13.
1996: Lutz G Schmidt; Michael Dettling; K J Graef; A Heinz; S Kuhn; J Podschus; Hans Rommelspacher
Reduced dopaminergic function in alcoholics is related to severe dependence.
Biological psychiatry 1996;39(3):193-8.
1995: Michael Dettling; A Heinz; P Dufeu; Hans Rommelspacher; KJ Gräf; Lutz G Schmidt
Dopaminergic responsivity in alcoholism: trait, state, or residual marker?
The American journal of psychiatry 1995;152(9):1317-21.
1995: A Heinz; Michael Dettling; S Kuhn; P Dufeu; KJ Gräf; I Kürten; Hans Rommelspacher; I G Schmidt
Blunted growth hormone response is associated with early relapse in alcohol-dependent patients.
Alcoholism, clinical and experimental research 1995;19(1):62-5.
1995: A Heinz; B Lichtenberg-Kraag; S S Baum; K Graf; F Kruger; Michael Dettling; Hans Rommelspacher
Evidence for prolonged recovery of dopaminergic transmission after detoxification in alcoholics with poor treatment outcome.
Journal of neural transmission. General section 1995;102(2):149-57.